human
lactat
dehydrogenas
tetramer
enzym
highli
express
smooth
muscl
ldh
subtyp
upregul
divers
tumor
tissu
includ
lung
pheochromocytoma
paraganglioma
esophag
squamou
cell
carcinoma
breast
endometri
adenocarcinoma
ovarian
cystadenocarcinoma
hereditari
leiomyomatosi
renal
carcinoma
colon
carcinoma
unlik
normal
differenti
cell
lactat
accumul
occur
anaerob
cancer
cell
readili
convert
glucos
lactat
aerob
phenomenon
term
warburg
effect
elev
protein
express
enzym
function
contributor
accumul
lactat
also
aggress
tumor
growth
advanc
progress
metastasi
acid
subsequ
resist
radiat
chemotherapi
knockdown
lower
function
capac
ldha
suppress
tumor
growth
metastasi
indic
enzym
could
serv
novel
target
cancer
therapi
strategi
studi
elucid
inhibitori
effect
commonli
use
medicin
herbal
extract
rom
around
world
plant
herbal
extract
macer
dice
chop
homogen
ethanol
sampl
place
rocker
shaker
hour
store
air
tight
contain
dark
serial
dilut
made
use
diluent
consist
hbss
hepe
adjust
ph
recombin
full
length
human
ldha
amino
acid
n
termin
tag
amino
acid
tag
mw
kda
enzym
commiss
ec
number
brenda
iubmb
abcam
cambridg
util
protein
valid
proteom
analysi
use
matrix
assist
laser
desorpt
ioniz
maldi
mass
spec
msm
analyz
mascot
id
briefli
pure
enzym
solubil
denatur
subject
sd
page
gel
electrophoresi
use
trishcl
gradient
gel
run
buffer
mm
tri
mm
glycin
sd
v
minut
high
intens
band
ldha
kd
visual
gbioscienc
labsaf
gel
stain
excis
follow
gel
digest
peptid
trypsin
follow
reductionalkyl
dtt
iodoacetamid
respect
sampl
analyz
use
maldi
msm
appli
biosystem
protein
sequenc
identifi
mascot
analysi
continu
ldha
assay
use
conduct
highthroughput
screen
ht
briefli
buffer
consist
hbss
calcium
magnesium
ph
adjust
ldha
enzym
final
concentr
unitsml
ad
treatment
tier
one
concentr
mgml
addit
adenin
dinucleotid
reduc
form
solut
final
work
concentr
preread
establish
reaction
start
solut
substrat
pyruv
final
concentr
rapid
screen
model
use
base
work
previous
describ
enzym
microarray
format
adapt
well
plate
contain
known
concentr
enzym
treatment
equal
concentr
dissolv
buffer
hbss
addit
substrat
pyruv
curv
time
depend
nadh
oxid
monitor
continu
minut
first
tier
investig
establish
final
work
concentr
mgml
herbal
extract
compound
inhibit
ldha
first
tier
screen
control
place
second
tier
final
concentr
mgml
third
tier
final
concentr
mgml
fourth
tier
final
concentr
extend
rang
mgml
extract
rank
potenc
potent
evalu
minimum
concentr
less
mgml
establish
enzym
microarray
format
rapid
reproduc
repeatedli
corrobor
fourtier
evalu
process
statist
analysi
perform
use
graph
pad
prism
version
graph
pad
softwar
inc
san
diego
ca
usa
signific
differ
group
assess
use
oneway
anova
follow
tukey
post
hoc
mean
comparison
test
two
way
anova
student
test
determin
regress
analysi
use
origin
softwar
originlab
northampton
method
valid
establish
monitor
continu
nadh
oxid
initi
addit
substrat
pyruv
acid
presenc
vari
enzym
concentrationtim
fig
screen
valid
process
establish
use
uml
ldha
minut
fig
known
inhibitor
oxal
acid
fig
data
show
slow
steadi
rate
reaction
result
time
depend
od
decay
minut
high
signalnois
ratio
although
enzym
use
screen
describ
recombin
full
length
human
ldha
amino
acid
n
termin
tag
amino
acid
tag
mw
kda
enzym
commiss
ec
number
brenda
iubmb
abcam
cambridg
confirm
ident
enzym
use
matrix
assist
laser
desorpt
ionis
maldi
mass
spec
msm
analysi
mascot
id
fig
fig
top
panel
show
sd
page
gel
electrophoresi
purifi
enzym
three
concentr
right
along
molecular
marker
standard
left
gel
band
excis
digest
analyz
msm
peptid
sequenc
protein
identifi
bottom
panel
data
show
posit
hit
human
ldha
confid
interv
peptidesequ
mass
high
throughput
enzym
microarray
model
use
work
extract
equal
concentr
mgml
dissolv
buffer
hbss
incub
enzym
minut
prior
start
reaction
addit
substrat
curv
time
depend
product
format
monitor
continu
minut
fig
repres
minut
read
taken
origin
screen
valu
compound
sort
accord
inhibitori
potenc
initi
test
extract
inhibit
ldha
within
first
tier
control
denot
red
dot
line
fig
plant
extract
subject
second
tier
screen
final
concentr
mgml
third
tier
screen
final
concentr
mgml
fourth
tier
screen
final
concentr
extend
rang
mgml
regress
analysi
use
calcul
retest
extract
show
mgml
tabl
list
potenc
rank
full
inhibitori
dose
respons
curv
shown
top
four
inhibitor
fig
tabl
human
ldha
inhibitor
potenc
extract
list
mgml
inhibit
nadh
oxid
ldha
ht
studi
investig
ethanol
extract
natur
product
identifi
human
ldha
inhibitor
properti
result
show
melaphi
chinensi
gallnut
also
known
rhu
chinensi
rc
nut
potent
within
therapeut
rang
rhu
chinensi
belong
famili
anacardiacea
genu
rhu
famili
consist
speci
found
china
mani
locat
around
world
numer
tradit
chines
herbalist
recommend
rc
ailment
chronic
cough
due
lung
defici
chronic
diarrhea
clear
toxin
unfortun
claim
base
scientif
ground
yet
interest
herb
continu
increas
numer
scientif
base
find
abund
research
biolog
pharmacolog
benefit
rc
exampl
shown
effect
harm
intestin
periodont
bacteri
growth
inhibit
mechan
mediat
part
constitu
gallic
acid
gallotaninn
antivir
rc
ethyl
acet
extract
inhibitori
effect
hepat
carcinoma
viru
sever
acut
respiratori
syndrom
corona
viru
pgg
isol
rc
show
promis
hepatoprotect
properti
anticanc
effect
rc
believ
involv
inhibit
phosphotas
activ
gallic
acid
one
bioactiv
compon
rc
directli
induc
apoptosi
prostat
cancer
cell
pgg
also
shown
huh
et
al
constitu
rc
abil
inhibit
angiogenesi
stimul
apoptosi
addit
pgg
reduc
cancer
cell
viabil
well
suppress
prostat
cancer
bone
metastasi
caus
cell
cycl
arrest
phase
find
studi
broad
show
number
natur
product
abil
inhibit
ldha
may
advers
affect
cancer
cell
surviv
present
evid
ldha
inhibitori
properti
number
commonli
use
herb
spice
previous
report
anticanc
properti
includ
bladderwrack
kelp
cinnamon
cat
claw
bark
arjun
polygonum
multiflorum
witch
hazel
futur
research
requir
evalu
ldha
inhibit
contribut
factor
tumoricid
antiprolif
properti
herb
divers
human
cancer
cell
